- Learn the basics
- Find stocks
- Understand a stock
AEON Biopharma, Inc.
AEON United States NYSEAEON Biopharma, Inc. is a clinical-stage biopharmaceutical company that develops and seeks to commercialize a proprietary botulinum toxin type A complex, ABP-450, for therapeutic use. The company’s sole product candidate is administered via intramuscular injection and is under evaluation for multiple indications, including chronic migraine, cervical dystonia, and other neurologic and pain-related conditions. The company operates in a single reportable segment focused on the research, clinical development, regulatory approval, and future commercialization of botulinum toxin therapeutics. Its activities target physician-administered markets within neurology, pain management, and related therapeutic categories in the United States and select international jurisdictions.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company and how factual it is. What the ratings mean.